Panacea Biotec has entered into joint collaboration for Development, License, Manufacturing, Supply and Sales of 7 complex generic pharmaceutical products with Bionpharma Inc., a generic pharmaceutical company based in the United States. The joint collaboration is established for research, development and manufacturing activities for commercialization of 7 Abbreviated New Drug Applications (ANDAs), which are currently under development at Panacea Biotec, representing a total estimated market potential of more than $800 million.
Under the collaboration, Panacea Biotec will be responsible for development, filing, registration, manufacturing & supply of these ANDAs, while Bionpharma Inc. will be responsible for importation, warehousing, sales and distribution of these ANDAs in the United States and its territories. Under this joint collaboration, both companies intend to expand the scope of their alliance by adding new products to the collaboration from time to time.
Panacea Biotec is a leading biotechnology company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and leading Biotechnology Companies in India.
